Ariel Miller - Concepedia

Author

Ariel Miller

Also Known As

A Edgar Miller, A Miller, A. Edgar Miller, A. MILLER, A. Miller, A.Edgar Miller, ARIEL MILLER, Ariel Miller, David H. Miller, David Miller

209

Publications

11.1K

Citations

H-Index

177

Concepts

All Affiliations

Carmel Medical Center Technion – Israel Institute of Technology Rappaport Family Institute for Research in the Medical Sciences Brigham and Women's Hospital Harvard University

About

Ariel Miller is an author at Carmel Medical Center specializing in medicine, immunology, and multiple sclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	59	4.5K
2	Health Sciences	2	2	102
3	Education	1	1	28
4	Engineering	1	1	133
5	Natural Sciences	1	1	78

Ariel Miller

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
Tumor Necrosis Factor-α Frank C. Barone, B. Mak Arvin, Ray F. White, Stroke	1997	861
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Ariel Miller, Ofer Lider, Anita B. Roberts, Proceedings of the National Academy of Sciences T-regulatory CellImmunologyImmune RegulationPathologyImmunotherapy	1992	728
Antigen-driven bystander suppression after oral administration of antigens. Ariel Miller, Ofer Lider, Howard L. Weiner The Journal of Experimental Medicine Modulator Spleen CellsImmunologyAntigen-driven Bystander SuppressionImmunodominanceAntigen Processing	1991	435
Health-related Quality of Life in Multiple Sclerosis: The Impact of Disability, Gender and Employment Status Ariel Miller, Sara Dishon Quality of Life Research Family MedicineQuality Of LifeLife AssessmentHealth-related QualitySocial Health	2006	281
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring Ludwig Kappos, David O. Bates, Gilles Edan, The Lancet Neurology Translational MedicineSystemic SclerodermaMedicineImmunologyClinical Trials	2011	265
Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells Hirofumi Ochi, Michal Abraham, Hiroki Ishikawa, Nature Medicine Autoimmune DiseaseAllergyImmunologyAutoimmunityT Cell Immunity	2006	235
Treatment of multiple sclerosis with Copolymer-1 (Copaxone®): implicating mechanisms of Th1 to Th2/Th3 immune-deviation Ariel Miller, Sarah Shapiro, Rosa Gershtein, Journal of Neuroimmunology Autoimmune DiseaseMedicineImmune RegulationImmunologyNeurological Progress	1998	228
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis Hillel Panitch, Ronald A. Thisted, Richard Smith, Annals of Neurology	2006	175
Regulation of Endothelial Matrix Metalloproteinase-2 by Hypoxia/Reoxygenation Yaara Ben-Yosef, Nitza Lahat, Sarah Shapiro, Circulation Research Mmp FamilyImmunologyEc Mmp-2Redox BiologyEnzyme Secretion	2002	170
Epitopes of myelin basic protein that trigger TGF-<i>beta</i> release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. Ariel Miller, A AL-Sabbagh, Liliane Martins dos Santos, The Journal of Immunology	1993	156

Page 1